Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,885 | 179 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $893.24 | 62 | $0 (2024) |
| Lilly USA, LLC | $483.62 | 27 | $0 (2024) |
| Novo Nordisk Inc | $391.38 | 24 | $0 (2024) |
| PFIZER INC. | $253.97 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $127.57 | 8 | $0 (2024) |
| Exact Sciences Corporation | $119.13 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $68.36 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $65.33 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $58.54 | 4 | $0 (2024) |
| Abbott Laboratories | $52.15 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,510 | 96 | ABBVIE INC. ($566.27) |
| 2023 | $1,302 | 79 | ABBVIE INC. ($326.97) |
| 2022 | $72.38 | 4 | Biohaven Pharmaceutical Holding Company Ltd. ($25.88) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Cardio-renal | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: Cranial Orthotic | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: VACCINE | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $12.65 | General |
| 09/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Obesity | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Obesity | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 499 | 643 | $129,830 | $50,165 |
| 2022 | 3 | 83 | 89 | $20,623 | $7,452 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 177 | $43,011 | $15,881 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 168 | $28,896 | $9,802 | 33.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 58 | 58 | $14,384 | $7,088 | 49.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $12,190 | $6,492 | 53.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $21,942 | $6,397 | 29.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 27 | 27 | $3,969 | $1,942 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $1,682 | $829.40 | 49.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 20 | 20 | $1,500 | $657.78 | 43.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $1,232 | $629.20 | 51.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 24 | $816.00 | $389.28 | 47.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 26 | $208.00 | $57.20 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $7,632 | $2,508 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 26 | $6,318 | $2,473 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 39 | $6,673 | $2,472 | 37.0% |
About Dr. Mary Manley, MD
Dr. Mary Manley, MD is a Pediatrics healthcare provider based in La Grange, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2017. The National Provider Identifier (NPI) number assigned to this provider is 1942732912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Manley, MD has received a total of $2,885 in payments from pharmaceutical and medical device companies, with $1,510 received in 2024. These payments were reported across 179 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,885).
As a Medicare-enrolled provider, Manley has provided services to 582 Medicare beneficiaries, totaling 732 services with total Medicare billing of $57,617. Data is available for 2 years (2022–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine, Internal Medicine
- Location La Grange, KY
- Active Since 03/29/2017
- Last Updated 09/05/2025
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1942732912
Products in Payments
- VRAYLAR (Drug) $579.96
- MOUNJARO (Drug) $374.32
- QULIPTA (Drug) $224.29
- Wegovy (Drug) $187.33
- JARDIANCE (Drug) $126.44
- COMIRNATY (Biological) $121.01
- Cologuard Collection Kit (Device) $119.13
- TRELEGY ELLIPTA (Drug) $110.30
- Ozempic (Drug) $98.97
- Rybelsus (Drug) $93.48
- UBRELVY (Drug) $88.99
- Kerendia (Drug) $68.36
- GARDASIL (Biological) $65.33
- NURTEC ODT (Drug) $65.20
- PREVNAR 20 (Biological) $59.46
- FREESTYLE LIBRE (Device) $52.15
- Heplisav-B (Drug) $38.52
- Repatha (Biological) $34.65
- QUVIVIQ (Drug) $31.14
- FARXIGA (Drug) $28.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in La Grange
Dr. Katherine Jett, M.d, M.D
Pediatrics — Payments: $5,269
Amy Bindner, M.d, M.D
Pediatrics — Payments: $3,488
John Wehry
Pediatrics — Payments: $2,575
Ms. Ashli Collins, M.d, M.D
Pediatrics — Payments: $1,907
Mrs. Julie Schuster, M.d, M.D
Pediatrics — Payments: $1,576
Mrs. Diane Wetherton, M.d, M.D
Pediatrics — Payments: $1,478